AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ebunat 0.5mg Injection

Prescription Icon
Prescription Required

Marketer

Natco Pharma Ltd

Salt Composition

Eribulin Mesylate (0.5mg)

Overview Ebunat 0.5mg Injection

Oncaspar 0.5mg Injection is indicated for advanced breast cancer treatment in adults. This therapy targets patients whose cancer has metastasized and who have undergone prior anticancer regimens. Oncaspar 0.5mg Injection may be administered alone or in conjunction with other medications as part of a combined chemotherapy approach. Intravenous administration should always be performed under strict medical supervision. Dosage and frequency are determined by the physician based on individual patient needs and may vary. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse events. While therapeutic benefits may not be immediately apparent, and could take weeks or months, discontinuation should only occur under a doctor's guidance. Commonly reported side effects include fatigue, alopecia, nausea, and bowel irregularity. This medication can also suppress blood cell production, increasing infection risk; therefore, regular blood tests, alongside cardiac, hepatic, uric acid, and electrolyte monitoring, are essential. Peripheral neuropathy, manifesting as numbness, tingling, or pins and needles in the extremities, may occur. Consult your doctor immediately if these symptoms are bothersome or persistent. Prior to commencing treatment, inform your physician of any pre-existing cardiac, hepatic, or renal conditions, as well as any concomitant medications, particularly anti-infectives. Interactions with other drugs are possible, so comprehensive medication disclosure is vital. This injection is contraindicated in pregnancy and lactation. Reliable contraception for both partners is strongly recommended throughout the treatment period to prevent pregnancy.

Primary Ingredients of Ebunat 0.5mg Injection

No text provided. Please provide the text you would like me to rephrase.

Uses of Ebunat 0.5mg Injection

Breast cancer with distant spread

Major Benefits of Ebunat 0.5mg Injection:

This medication will be administered by your healthcare provider; self-medication is strongly discouraged.

Common Side effects of Ebunat 0.5mg Injection:

  • Anemia (low number of red blood cells)
  • Weakness
  • Hair loss
  • Nausea
  • Constipation
  • Decreased white blood cell count
  • Fatigue
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Ebunat 0.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Ebunat 0.5mg Injection works:

Ebunat 0.5mg injection is a cancer treatment that disrupts the microtubule networks essential for cancer cell proliferation. This disruption halts the cancer cells' reproductive cycle, leading to their demise.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Ebunat 0.5mg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Ebunat 0.5mg Injection during pregnancy poses a confirmed risk to the fetus. Its use should be strictly avoided except in exceptional, life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Administering Ebunat 0.5mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Administering Ebunat 0.5mg Injection might cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Ebunat 0.5mg Injection cautiously. The prescribed dosage of Ebunat 0.5mg Injection might require modification. A physician's consultation is recommended.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Ebunat 0.5mg Injection. Dosage modification for Ebunat 0.5mg Injection may be necessary. Physician consultation is advised.

What if you forget to take Ebunat 0.5mg Injection :

NA

Facts to Know About Ebunat 0.5mg Injection

LabelValue
Chemical Type Halichondrin B analog
Developing Habits No.
Type of Therapy Cancer Medications
Actions Microtubule-targeting agents (excluding taxanes)

FAQs on Ebunat 0.5mg Injection

Ebunat 0.5mg Injection may cause hair loss, a side effect that can be reversible but varies in severity. Discuss any hair loss concerns with your doctor.
Ebunat 0.5mg injections are typically administered on days 1 and 8 of each 21-day treatment cycle. Treatment length is individualized, with the total number of cycles determined by your doctor. Blood test results may necessitate postponing or dose adjustment as directed by your physician.
A doctor or healthcare professional will administer Ebunat 0.5mg Injection intravenously over 2 to 5 minutes. Dosage, determined by your body surface area (m²), calculated from your weight and height, may be adjusted based on blood test results and other factors. Following administration, a saline flush is recommended to ensure complete delivery of the Ebunat 0.5mg Injection.
Ebunat 0.5mg Injection carries serious risks, including dangerously low white blood cell counts (neutropenia), potentially causing fatal infections. Numbness, tingling, or pain in the hands and feet (peripheral neuropathy) is also possible; this common side effect can be severe. Use during pregnancy may harm the baby.
Women of childbearing age must use effective contraception for three months following Ebunat 0.5mg Injection treatment. This medication may cause severe birth defects and should be avoided during pregnancy unless deemed absolutely essential after thorough risk assessment for both mother and child.
Handle Ebunat 0.5mg Injection with care, avoiding contact with skin, eyes, mouth, or nose. Wear gloves, goggles, and protective clothing. In case of skin contact, wash thoroughly with soap and water. If contact occurs with eyes, mouth, or nose, flush immediately with water. Pregnant personnel should not handle this injection.
Ebunat 0.5mg Injection can be diluted with up to 100ml of 0.9% sodium chloride solution, but not 5% dextrose. Administration requires a physician experienced in cancer chemotherapy and must be performed by a qualified healthcare professional.
Ebunat 0.5mg Injection
16,088
MRP 19,600
17% off